Intel has introduced a collaboration with the Broad Institute of MIT and Harvard, to help healthcare researchers share and system essential healthcare data in the struggle towards cancer. The goal of the new collaboration is to pace up genomic exploration. Genomic data includes the sequence of an individual’s DNA and is vital for developing specific therapies for cancer, but the duration of time it currently normally takes to order and converse this data is holding back exploration. To help, the Broad Institute is partnering with Intel to offer cloud-based accessibility to its Genome Analysis Toolkit (GATK) software program package, and to co-create new tools that will make it less difficult for researchers to retailer and system broad quantities of genomic data, and help healthcare specialists arrive up with specific treatment strategies for individuals. Intel is already using cloud-based analytic tools across collective data sets from Oregon Health Sciences University (OHSU), the Dana-Farber Most cancers Institute (DFCI) and the Ontario Institute for Most cancers Analysis (OICR) – as component of its Collaborative Most cancers Cloud task, very first introduced at IDF 2015. “The things we are accomplishing with the Broad is just heading to make execution these tools inside of that collaborative atmosphere speedier, superior and more cost-effective,” claimed Bryce Olson, worldwide marketing director of Health and Existence Sciences at Intel. “Then as the collaborative cancer cloud expands and grows, it’s heading to help researchers explore factors speedier and make factors for individuals like myself that considerably superior.” Olson is himself a cancer survivor, many thanks in component to a specific drug treatment prepare that resulted from genomic sequencing data. He explained to me that the partnership with the Broad Institute is the most up-to-date in Intel’s efforts to aid a new stage of collaboration in healthcare exploration. “If you can consider it, today with genomic data there is definitely no databases,” claimed Olson. “There’s no standard databases at all. When you happen to be doing the job on some thing like jogging GATK for variant discovery, you happen to be basically studying and crafting to these large text documents. For the very first time now there is heading to be an genuine databases that can make factors speedier.”
The tools staying developed consist of GenomicsDB, an optimised version of TileDB, which was developed by MIT and Intel researchers doing the job at the Intel Science and Engineering Middle for Significant Knowledge. There is also Cromwell, a workflow execution motor that is staying prolonged to assistance numerous enter languages and execute on numerous backends concurrently. Equally TileDB and GenomicsDB are staying produced as open source tools. The partnership with the Broad marks the most up-to-date milestone in Intel’s widening Collaborative Most cancers Cloud. At the finish of March, the Dana-Farber Most cancers Institute and the Ontario Institute for Most cancers Analysis joined the massive data task, and Olson thinks collaborative genomic investigation will continue on to create as a vital weapon in the struggle towards cancer and other life-threatening diseases. “In the long term, I see all cancer individuals will get genomic sequencing,” Olson explained to me. “The mutations that are found in their tumours will be identified and comprehended. There will be a immediate url amongst these mutations and specific treatment strategies that will flip cancer into a workable disease.”
Supply url Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window)
Related
Intel has introduced a collaboration with the Broad Institute of MIT and Harvard, to help healthcare researchers share and system essential healthcare data in the struggle towards cancer.
The goal of the new collaboration is to pace up genomic exploration. Genomic data includes the sequence of an individual’s DNA and is vital for developing specific therapies for cancer, but the duration of time it currently normally takes to order and converse this data is holding back exploration.
To help, the Broad Institute is partnering with Intel to offer cloud-based accessibility to its Genome Analysis Toolkit (GATK) software program package, and to co-create new tools that will make it less difficult for researchers to retailer and system broad quantities of genomic data, and help healthcare specialists arrive up with specific treatment strategies for individuals.
Intel is already using cloud-based analytic tools across collective data sets from Oregon Health Sciences University (OHSU), the Dana-Farber Most cancers Institute (DFCI) and the Ontario Institute for Most cancers Analysis (OICR) – as component of its Collaborative Most cancers Cloud task, very first introduced at IDF 2015.
“The things we are accomplishing with the Broad is just heading to make execution these tools inside of that collaborative atmosphere speedier, superior and more cost-effective,” claimed Bryce Olson, worldwide marketing director of Health and Existence Sciences at Intel. “Then as the collaborative cancer cloud expands and grows, it’s heading to help researchers explore factors speedier and make factors for individuals like myself that considerably superior.”
Olson is himself a cancer survivor, many thanks in component to a specific drug treatment prepare that resulted from genomic sequencing data. He explained to me that the partnership with the Broad Institute is the most up-to-date in Intel’s efforts to aid a new stage of collaboration in healthcare exploration.
“If you can consider it, today with genomic data there is definitely no databases,” claimed Olson. “There’s no standard databases at all. When you happen to be doing the job on some thing like jogging GATK for variant discovery, you happen to be basically studying and crafting to these large text documents. For the very first time now there is heading to be an genuine databases that can make factors speedier.”
The tools staying developed consist of GenomicsDB, an optimised version of TileDB, which was developed by MIT and Intel researchers doing the job at the Intel Science and Engineering Middle for Significant Knowledge. There is also Cromwell, a workflow execution motor that is staying prolonged to assistance numerous enter languages and execute on numerous backends concurrently. Equally TileDB and GenomicsDB are staying produced as open source tools.
The partnership with the Broad marks the most up-to-date milestone in Intel’s widening Collaborative Most cancers Cloud. At the finish of March, the Dana-Farber Most cancers Institute and the Ontario Institute for Most cancers Analysis joined the massive data task, and Olson thinks collaborative genomic investigation will continue on to create as a vital weapon in the struggle towards cancer and other life-threatening diseases.
“In the long term, I see all cancer individuals will get genomic sequencing,” Olson explained to me. “The mutations that are found in their tumours will be identified and comprehended. There will be a immediate url amongst these mutations and specific treatment strategies that will flip cancer into a workable disease.”